25.10.09:
Synectix to present their latest formulation research at Drug Delivery to the Lungs (DDL) Conference 2009

Synectix Pharmaceutical Solutions Ltd are pleased to announce their forthcoming attendance at the 2009 Drug Delivery to the Lungs (DDL) conference in Edinburgh between 8th – 12th December 2009.

Through an ongoing successful collaboration with Novartis Pharma, Synectix will be presenting it's latest research into pMDI product development, entitled:

• Study of HFA pMDI formulations by NMR: Solubility and stability measurements

Synectix representatives will be available to discuss this work throughout the conference. To arrange a meeting with us, please contact us directly. We look forward to seeing you in Edinburgh!